SEC-sourced researchBeta
TRAW
Traws Pharma, Inc.
Company comparison ↗
Data passport
- CIK
- 0001130598
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Apr 15, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 226,000.0000 | Apr 15, 2026 |
| December 2025 | 2,790,000.0000 | Apr 15, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 2,790,000.0000 | 9,170,000.0000 | -18,185,000.0000 | 10,617,000.0000 | 11,246,000.0000 | Apr 15, 2026 |
| December 2024 | 226,000.0000 | -166,523,000.0000 | -29,792,000.0000 | 24,962,000.0000 | 56,592,000.0000 | Apr 15, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $2.79M | December 2025 | Apr 15, 2026 | 10-K |
| Previous period revenueRevenues | $226K | December 2024 | Apr 15, 2026 | 10-K |
| Net incomeNetIncomeLoss | $9.17M | December 2025 | Apr 15, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$18.19M | December 2025 | Apr 15, 2026 | 10-K |
| Total assetsAssets | $10.62M | December 2025 | Apr 15, 2026 | 10-K |
| Total liabilitiesLiabilities | $11.25M | December 2025 | Apr 15, 2026 | 10-K |